Literature DB >> 24145520

Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany.

Sönke Andres1, Doris Hillemann, Sabine Rüsch-Gerdes, Elvira Richter.   

Abstract

Four out of 143 phenotypically isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis strains that were isolated from patients in Germany in 2011 had mutations in the rifampin resistance-determining region of rpoB. After performing drug susceptibility testing (DST) with two methods, the proportion method on Löwenstein-Jensen medium and using the Bactec 960 Mycobacteria Growth Indicator Tube system, we conclude that the two methods are equally reliable for phenotypic DST and MIC determination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145520      PMCID: PMC3910775          DOI: 10.1128/AAC.01752-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Disequilibrium in distribution of resistance mutations among Mycobacterium tuberculosis Beijing and non-Beijing strains isolated from patients in Germany.

Authors:  Doris Hillemann; Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

2.  Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants.

Authors:  Emma Huitric; Jim Werngren; Pontus Juréen; Sven Hoffner
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

3.  Use of the BACTEC Mycobacteria Growth Indicator Tube 960 automated system for recovery of Mycobacteria from 9,558 extrapulmonary specimens, including urine samples.

Authors:  Doris Hillemann; Elvira Richter; Sabine Rüsch-Gerdes
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

4.  Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level.

Authors:  A Telenti; N Honoré; C Bernasconi; J March; A Ortega; B Heym; H E Takiff; S T Cole
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.

Authors:  H Ohno; H Koga; S Kohno; T Tashiro; K Hara
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment.

Authors:  Jennifer Ho; Peter Jelfs; Vitali Sintchencko
Journal:  J Antimicrob Chemother       Date:  2013-07-09       Impact factor: 5.790

7.  Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland.

Authors:  Anna Sajduda; Anna Brzostek; Marta Poplawska; Ewa Augustynowicz-Kopec; Zofia Zwolska; Stefan Niemann; Jaroslaw Dziadek; Doris Hillemann
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

8.  Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Elvira Richter
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

9.  Low-cost rapid detection of rifampicin resistant tuberculosis using bacteriophage in Kampala, Uganda.

Authors:  Hamidou Traore; Sam Ogwang; Kim Mallard; Moses L Joloba; Francis Mumbowa; Kalpana Narayan; Susan Kayes; Edward C Jones-Lopez; Peter G Smith; Jerrold J Ellner; Roy D Mugerwa; Kathleen D Eisenach; Ruth McNerney
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-01-09       Impact factor: 3.944

10.  Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong.

Authors:  Raphael C Y Chan; Mamie Hui; Edward W C Chan; T K Au; Miu L Chin; Chun K Yip; Carrie K W AuYeang; Christina Y L Yeung; Kai M Kam; Peter C W Yip; Augustine F B Cheng
Journal:  J Antimicrob Chemother       Date:  2007-03-14       Impact factor: 5.790

View more
  9 in total

1.  Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs.

Authors:  Zohar B Weinstein; Muhammad H Zaman
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Diagnostic Accuracy and Utility of FluoroType MTBDR, a New Molecular Assay for Multidrug-Resistant Tuberculosis.

Authors:  Margaretha de Vos; Brigitta Derendinger; Tania Dolby; John Simpson; Paul D van Helden; John E Rice; Lawrence J Wangh; Grant Theron; Robin M Warren
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

3.  Retrospective Analysis of False-Positive and Disputed Rifampin Resistance Xpert MTB/RIF Assay Results in Clinical Samples from a Referral Hospital in Hunan, China.

Authors:  Peilei Hu; Hongtai Zhang; Joy Fleming; Guofeng Zhu; Shuai Zhang; Yaguo Wang; Fengping Liu; Songlin Yi; Zhongnan Chen; Zhenhua Chen; Binbin Liu; Daofang Gong; Li Wan; Xingyun Wang; Yunhong Tan; Liqiong Bai; Lijun Bi
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

4.  Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.

Authors:  Federica Fregonese; Shama D Ahuja; Onno W Akkerman; Denise Arakaki-Sanchez; Irene Ayakaka; Parvaneh Baghaei; Didi Bang; Mayara Bastos; Andrea Benedetti; Maryline Bonnet; Adithya Cattamanchi; Peter Cegielski; Jung-Yien Chien; Helen Cox; Martin Dedicoat; Connie Erkens; Patricio Escalante; Dennis Falzon; Anthony J Garcia-Prats; Medea Gegia; Stephen H Gillespie; Judith R Glynn; Stefan Goldberg; David Griffith; Karen R Jacobson; James C Johnston; Edward C Jones-López; Awal Khan; Won-Jung Koh; Afranio Kritski; Zhi Yi Lan; Jae Ho Lee; Pei Zhi Li; Ethel L Maciel; Rafael Mello Galliez; Corinne S C Merle; Melinda Munang; Gopalan Narendran; Viet Nhung Nguyen; Andrew Nunn; Akihiro Ohkado; Jong Sun Park; Patrick P J Phillips; Chinnaiyan Ponnuraja; Randall Reves; Kamila Romanowski; Kwonjune Seung; H Simon Schaaf; Alena Skrahina; Dick van Soolingen; Payam Tabarsi; Anete Trajman; Lisa Trieu; Velayutham V Banurekha; Piret Viiklepp; Jann-Yuan Wang; Takashi Yoshiyama; Dick Menzies
Journal:  Lancet Respir Med       Date:  2018-04       Impact factor: 102.642

5.  Frequency and Type of Disputed rpoB Mutations in Mycobacterium tuberculosis Isolates from South Korea.

Authors:  Kyung-Wook Jo; Soyeon Lee; Mi Ran Kang; Heungsup Sung; Mi-Na Kim; Tae Sun Shim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-07-03

6.  Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis.

Authors:  Diana Machado; Tatiane S Coelho; João Perdigão; Catarina Pereira; Isabel Couto; Isabel Portugal; Raquel De Abreu Maschmann; Daniela F Ramos; Andrea von Groll; Maria L R Rossetti; Pedro A Silva; Miguel Viveiros
Journal:  Front Microbiol       Date:  2017-04-27       Impact factor: 5.640

7.  Molecular characterization of rpoB gene mutations in isolates from tuberculosis patients in Cubal, Republic of Angola.

Authors:  Ariadna Rando-Segura; María Luisa Aznar; María Milagros Moreno; Mateu Espasa Soley; Elena Sulleiro Igual; Cristina Bocanegra Garcia; Eva Gil Olivas; Arlete Nindia Eugénio; Carlos Escartin Huesca; Adriano Zacarias; Josep Vegue Collado; Domingos Katimba; Maria Carmen Vivas Cano; Estevao Gabriel; Maria Teresa López García; Tomas Pumarola Suñe; Israel Molina Romero; María Teresa Tórtola Fernández
Journal:  BMC Infect Dis       Date:  2021-10-12       Impact factor: 3.090

8.  Detection of Mycobacterium tuberculosis Rifampicin Resistance Conferred by Borderline rpoB Mutations: Xpert MTB/RIF is Superior to Phenotypic Drug Susceptibility Testing.

Authors:  Hui Xia; Yuanyuan Song; Yang Zheng; Shengfen Wang; Bing Zhao; Wencong He; Dongxin Liu; Xichao Ou; Yang Zhou; Yanlin Zhao
Journal:  Infect Drug Resist       Date:  2022-03-29       Impact factor: 4.003

9.  Diagnostic Evaluation of Non-Interpretable Results Associated with rpoB Gene in Genotype MTBDRplus Ver 2.0.

Authors:  Binit Kumar Singh; Rohini Sharma; Parul Kodan; Manish Soneja; Pankaj Jorwal; Neeraj Nischal; Ashutosh Biswas; Sanjay Sarin; Ranjani Ramachandran; Naveet Wig
Journal:  Tuberc Respir Dis (Seoul)       Date:  2020-08-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.